migraine treatment
Japan’s Shin Nippon Biomedical Labs to buy US-based Satsuma for nasal powder migraine drug
Developed by Satsuma, STS101 is a nasal powder formulation of the anti-migraine drug, dihydroergotamine mesylate.
Japan’s Shin Nippon Biomedical Labs to buy US-based Satsuma for nasal powder migraine drug
Developed by Satsuma, STS101 is a nasal powder formulation of the anti-migraine drug, dihydroergotamine mesylate.
Drug approvals boost Japanese migraine treatment online
Some players have been highly active in digital channels of various countries.
Most Read
1. NUHCS to start using breakthrough drug for rare lung condition 2. Singapore and Saudi Arabia sign MoU on health cooperation 3. Sunway Healthcare Group, Syneos Health to expand clinical trial expertise 4. SingHealth names new CEO for Eastern General Hospital 5. Philippines’ AC Health and USAID partner to expand HIV careResource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
Event News
Ageing Singaporean population boosts demand for senior care innovations
![Ageing Singaporean population boosts demand for senior care innovations]()
Healthcare
Experts highlight AI and robotics as key drivers in transforming aged care.
Healthcare
Ageing Singaporean population boosts demand for senior care innovations
Experts highlight AI and robotics as key drivers in transforming aged care.
Videos
Partner Sites
Most Read
1. NUHCS to start using breakthrough drug for rare lung condition 2. Singapore and Saudi Arabia sign MoU on health cooperation 3. Sunway Healthcare Group, Syneos Health to expand clinical trial expertise 4. SingHealth names new CEO for Eastern General Hospital 5. Philippines’ AC Health and USAID partner to expand HIV careAwards
Apr
10